Abnormal neurotransmitter metabolite levels in Alzheimer patients with a delirium

International Journal of Geriatric Psychiatry

Volumn 21, Issue 9, 2006, Pages 838-843

  Van Der Cammen, Tischa J M ^a   Tiemeier, Henning ^a   Engelhart, Marianne J ^a   Fekkes, Durk ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Delirium; Plasma neurotransmitter metabolite levels

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID; NEUROTRANSMITTER;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DELIRIUM; FEMALE; HUMAN; MALE; METABOLITE; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACIDS; CASE-CONTROL STUDIES; DELIRIUM; FEMALE; HOMOVANILLIC ACID; HOSPITALIZATION; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; NEUROTRANSMITTER AGENTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 33749316390     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1569     Document Type: Article

References (38)

1. American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., revised (DSM-III-R). American Psychiatric Association: Washington, DC.
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edn., (DSM-IV). American Psychiatric Association: Washington, DC.
3. Basun H, Forssell LG, Almkvist O, et al. 1990. Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects. J Neural Transm Park Dis Dement Sect 2: 295-304.
4. Blennow K, Wallin A, Gottfries CG, et al. 1992. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease. Neurobiol Aging 13 (1): 107-113.
5. Copeland JRM, Kelleher MJ, Kellett JM, et al. 1976. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability. Psychol Med 6: 439-449.
6. Couvreur G, Demougeot C, Maugras C, Marie C, Beley P, Giroud M. 2002. 5-Hydroxyindolacetic acid and homovanillic acid are not involved in the cerebrospinal fluid after a seizure in patients with delirium tremens. Neurol Res 24(6): 599-600.
7. Degrell I, Nagy E. 1990. Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA and NA. Biol Psychiatry 27: 1179-1182.
8. Dringenberg HC. 2000. Alzheimer's disease: more than a 'cholinergic disorder'-evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav Brain Res 115(2): 235-249.
9. Fekkes D, van Dalen A, Edelman M, Voskuilen A. 1995. Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated derivatization with o-phthaldialdehyde. J Chromatogr B 669: 177-186.
10. Fekkes D, Timmerman L, Pepplinkhuizen L. 1997. Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression. Eur Neuropsychopharmacol 7: 235-239.
11. Fernström JD, Wurtman RJ. 1972. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178: 414-416.
12. Flacker JM, Lipsitz LA. 1999. Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol A Biol Sci Med Sci 54(6): B239-B246.
13. Folstein MF, Folstein SE, McHugh PR. 1975. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
14. Francis PT, Palmer AM, Snape M, Wilcock GK. 1999. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66: 137-147.
15. Haycock JW, Becker L, Ang L, Furukaway Y, Homykiewicz O, Kish SJ. 2003. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J Neurochem 87(3): 574-585.
16. Hofman A, Grobbee DE, de Jong PTVM, van den Ouweland FA. 1991. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7: 403-422.
17. Kaye JA, May C, Atack J, et al. 1988a. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease. Ann Neurol 24(5): 647-650.
18. Kaye JA, May C, Daly E, et al. 1988b. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features. Neurology 38(4): 554-557.
19. Kendler KS, Heninger GR, Roth RH. 1982. Influence of dopamine agonists on plasma and brain levels of homovanillic acid. Life Sci 30: 2063-2069.
20. Kohnke MD, Wiatr G, Kolb W, et al. 2003. Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. Neuropsychopharmacol 28(5): 1004-1010.
21. Koponen HJ, Lepola U, Leinonen E. 1995. A long-term follow-up study of cerebrospinal fluid 5-HIAA in delirium. Eur Arch Psychiatry Clin Neurosci 244: 131-134 .
22. Kumar AM, Sevush S, Kumar M, Ruiz J, Eisdorfer C. 1995. Peripheral serotonin in Alzheimer's disease. Neuropsychobiology 32(1): 9-12.
23. Lambert GW, Kaye DM, Cox HS, et al. 1995. Regional 5-hydroxyindoleacetic acid production in humans. Life Sci 57: 255-267.
24. Lopez OL, Kaufer D, Reiter CT, Carra J, DeKofky ST, Palmer AM. 1996. Relationship between CSF neurotransmitter metabolites and agressive behavior in Alzheimer's disease. Eur J Neurology 3(2): 153-155.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 34: 939-944.
26. Meltzer H. 1989. Serotonergic dysfunction in depression. Br J Psychiatry 155: 25-31.
27. Meltzer CC, Smith G, DeKosky ST, et al. 1999. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 21(2): 321-322.
28. Nakamura J, Uchimura N, Yamada S, Nakazawa Y. 1997. Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium. Int Clin Psychopharmacol 12(3): 147-152.
29. Parnetti L, Gaiti A, Reboldi GP, et al. 1992. CSF monoamine metabolites in old age dementias. Mol Chem Neuropathol 16(1-2): 143-157.
30. Reeves S, Bench C, Howard R. 2002. Ageing and the nigrostriatal dopaminergic system. Int J Geriatr Psychiatry 17(4): 359-370.
31. Rossor MN. 1982. Neurotransmitters and CNS disease: Dementia. Lancet 8309: 1200-1204.
32. Roth M, Tym E, Mountjoy CA, et al. 1986. CAMDEX: a standardised Instument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia. Br J Psychiatr 149: 698-709.
33. Sano H, Suzuki J, Ohara K, Miyasato K, Yokoyama T, Ohara K. 1994. Circadian variations in plasma monoamine metabolite levels in alcoholic patients: a possible predictor of alcohol withdrawal delirium. Prog Neuro-Psychopharmacol Biol Psychiatry 18(4): 741-752.
34. Sjoegren M, Minthon L, Passant U, Blennow K, Wallin A. 1998. Decreased monoamine metabolites in rontotemporal dementia and Alzheimer's disease. Neurobiol Aging 19(5): 379-384.
35. Sweet RA, Pollock BG, Mulsant BH, et al. 1997. Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report. Biol Psychiatry 42(11): 1016-1023.
36. Toghi H, Abe T, Takahashi S, Kimura M, Takahashi J, Kikuchi T. 1992. Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia. Neurosci Lett 141(1): 9-12.
37. Trzepacz PT, Mulsant BH, Dew MA, Pasternak R, Sweet RA, Zubenko GS. 1998. Is delirium different when it occurs in dementia? A study using the Delirium Rating Scale. J Neuropsychiatry Clin Neurosci 10(2): 199-204.
38. Van der Mast RC, Fekkes D. 2000. Serotonin and amino acids: partners in delirium pathophysiology? Semin Clin Neuropsychiatry 5(2): 125-131.